Funded: Master Lease Line of Credit for Early Stage Radiopharmaceutical Company

Customer is a privately held clinical stage radiopharmaceutical company, based out of Australia with an office in the United States. They are developing a complete portfolio of products for the management and treatment of cancer patients, from initial diagnosis to treatment planning, and monitoring to therapy. The customer is developing a comprehensive portfolio of radiopharmaceuticals for the management and treatment of cancer. Customer has developed molecular diagnostic techniques, e.g. the identification of the enzymes one person makes that another does not, to guide treatment decisions such as the choice of drugs that will be optimally metabolized by a particular patient.

The customer required a master lease line of credit to fund the IT equipment needs for the USA based office. United Capital Partners approved the transaction and successfully funded the equipment lease.